22298-29-9

22298-29-9 structure

Name: Betamethasone 17-benzoate
Chemical Name: [(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] benzoate
CAS Number: 22298-29-9
Molecular Formula: C₂₉H₃₃FO₆
Molecular Weight: 496.56700
Catalog: analytical chemistry Standard Pharmacopoeia Standards and Magazine Standards
Create Date: 2016-08-03 19:41:36
Modify Date: 2025-08-25 22:41:56
Betamethasone 17-benzoate is a representative steroid, which can be used in the treatment of recurrent aphothous ulcers (RAU).

Name	[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] benzoate
Synonyms	MS 1112 BETAMETHASONE BENZOATE Uticort (TN) Betamethasone benzoate Betamethasone 17-benzoate Benisone EINECS 244-897-9 W 5975

Description	Betamethasone 17-benzoate is a representative steroid, which can be used in the treatment of recurrent aphothous ulcers (RAU).
Related Catalog	Signaling Pathways >> Others >> Others Research Areas >> Inflammation/Immunology
In Vitro	Betamethasone 17-benzoate is the topical steroid[1]. Betamethasone 17-benzoate is a local corticosteroid[2]. A double-blind study of the effectiveness of Betamethasone 17-benzoate in the treatment of recurrent aphothous ulcers (RAU) is concucted. Betamethasone 17-benzoate is found to be effective in reducing symptoms and shortening healing time but not in preventing recurrences[3].
References	[1]. Barry BW, et al. Optimization of bioavailability of topical steroids: penetration enhancers under occlusion. J Invest Dermatol. 1984 Jan;82(1):49-52. [2]. ZFA (Stuttgart). 1978 Jul 10;54(19):1031-2. [3]. Merchant HW, et al. Betamethasone-17-benzoate in the treatment of recurrent aphthous ulcers. Oral Surg Oral Med Oral Pathol. 1978 Jun;45(6):870-5.

RIDADR	UN 2811 6.1 / PGII